David Hui1, Rony Dev2, Lindsay Pimental2, Minjeong Park3, Maria A Cerana2, Diane Liu3, Eduardo Bruera2. 1. Department of Palliative Care and Rehabilitation Medicine, MD Anderson Cancer Center, Houston, USA. Electronic address: dhui@mdanderson.org. 2. Department of Palliative Care and Rehabilitation Medicine, MD Anderson Cancer Center, Houston, USA. 3. Department of Biostatistics, MD Anderson Cancer Center, Houston, USA.
Abstract
CONTEXT: The ability to predict survival accurately has implications in clinical decision making. OBJECTIVES: We determined the association of phase angle obtained from multi-frequency bioelectric impedance analysis with overall survival in patients with advanced cancer. METHODS: We included consecutive patients with advanced cancer who had an outpatient palliative care consultation. Multi-frequency bioelectric impedance analysis assessed phase angle at three different frequencies (5/50/250 kHz) on each hemibody (right/left). Survival analysis was conducted using the Kaplan-Meier method, log-rank test, and multivariate Cox regression analysis. RESULTS: Among 366 patients, the median overall survival was 250 days (95% confidence interval 191-303 days). The mean phase angle for 5, 50, and 250 kHz were 2.2°, 4.4°, and 4.2° on the right and 2.0°, 4.2° and 4.1° on the left, respectively. For all six phase angles, a lower value was significantly associated with a poorer overall survival (P < 0.001). After adjusting for cancer type, performance status, weight loss, and inflammatory markers, phase angle remained independently associated with overall survival (hazard ratio 0.85 per degree increase, 95% confidence interval 0.72-0.99; P = 0.048). CONCLUSION: Phase angle represents a novel objective prognostic factor in outpatient palliative cancer care setting, regardless of frequency and body sides.
CONTEXT: The ability to predict survival accurately has implications in clinical decision making. OBJECTIVES: We determined the association of phase angle obtained from multi-frequency bioelectric impedance analysis with overall survival in patients with advanced cancer. METHODS: We included consecutive patients with advanced cancer who had an outpatient palliative care consultation. Multi-frequency bioelectric impedance analysis assessed phase angle at three different frequencies (5/50/250 kHz) on each hemibody (right/left). Survival analysis was conducted using the Kaplan-Meier method, log-rank test, and multivariate Cox regression analysis. RESULTS: Among 366 patients, the median overall survival was 250 days (95% confidence interval 191-303 days). The mean phase angle for 5, 50, and 250 kHz were 2.2°, 4.4°, and 4.2° on the right and 2.0°, 4.2° and 4.1° on the left, respectively. For all six phase angles, a lower value was significantly associated with a poorer overall survival (P < 0.001). After adjusting for cancer type, performance status, weight loss, and inflammatory markers, phase angle remained independently associated with overall survival (hazard ratio 0.85 per degree increase, 95% confidence interval 0.72-0.99; P = 0.048). CONCLUSION: Phase angle represents a novel objective prognostic factor in outpatient palliative cancer care setting, regardless of frequency and body sides.
Authors: Alan C Utter; David C Nieman; Gregory J Mulford; Richard Tobin; Sean Schumm; Tim McInnis; James R Monk Journal: Med Sci Sports Exerc Date: 2005-08 Impact factor: 5.411
Authors: Jochen G Raimann; Samer R Abbas; Li Liu; Fansan Zhu; Brett Larive; Peter Kotanko; Nathan W Levin; George A Kaysen Journal: Nephron Clin Pract Date: 2014-11-07
Authors: David Hui; Carlos Eduardo Paiva; Egidio G Del Fabbro; Christopher Steer; Jane Naberhuis; Marianne van de Wetering; Paz Fernández-Ortega; Tatsuya Morita; Sang-Yeon Suh; Eduardo Bruera; Masanori Mori Journal: Support Care Cancer Date: 2019-03-13 Impact factor: 3.603
Authors: Atsuko Miyazaki; Takashi Okuyama; Hayato Mori; Kazuhisa Sato; Keigo Kumamoto; Atsushi Hiyama Journal: Int J Environ Res Public Health Date: 2022-05-19 Impact factor: 4.614
Authors: Geraldo A Maranhao Neto; Iuliia Pavlovska; Anna Polcrova; Jeffrey I Mechanick; Maria M Infante-Garcia; Jose Medina-Inojosa; Ramfis Nieto-Martinez; Francisco Lopez-Jimenez; Juan P Gonzalez-Rivas Journal: J Clin Med Date: 2022-01-22 Impact factor: 4.241